China National Medicines Corporation Ltd. (600511.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 21.69B |
| Enterprise Value | 17.36B |
| P/E Ratio | 10.31 |
| PEG Ratio | -8.9 |
| Price/Sales Ratio | 0.37 |
| Price/Book Ratio | 1.01 |
| Enterprise/Revenue | 0.31 |
| Enterprise/EBITDA | 6.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 52.47B |
| Revenue/Share | 74.14 |
| Gross Profit | 3.46B |
| EBITDA | 2.87B |
| Net Income | 2B |
| Diluted EPS | 2.65 |
Balance Sheet
| Total Cash | 8.2B |
| Total Cash/Share | 11.35 |
| Total Debt | 3B |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.18 |
| Book Value Per Share | 28.5 |
Price History
| 52-Week Change | -12.52 |
| 52-Week High | 31.18 |
| 52-Week Low | 25.11 |
| Moving Average 50 Days | 27.3 |
| Moving Average 200 Days | 28.46 |
Statistics
| Average Volume | 4.83M |
| Shares Outstanding | 754.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.8 |
| Trailing Annual Dividend Yield | 3.03 |
| Payout Ratio | 0.01 |
| Last Split Factor | 2:1 |
| Last Split Date | June 03, 2009 |
AD
